Raymond James & Associates’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-444,705
| Closed | -$2.71M | – | 4157 |
|
|
2021
Q3 | $2.71M | Buy |
444,705
+80,529
| +22% | +$491K | ﹤0.01% | 1884 |
|
|
2021
Q2 | $3M | Buy |
364,176
+164,595
| +82% | +$1.35M | ﹤0.01% | 1830 |
|
|
2021
Q1 | $1.79M | Buy |
199,581
+1,208
| +0.6% | +$10.8K | ﹤0.01% | 2092 |
|
|
2020
Q4 | $2.29M | Sell |
198,373
-18,954
| -9% | -$219K | ﹤0.01% | 1810 |
|
|
2020
Q3 | $2.26M | Sell |
217,327
-5,219
| -2% | -$54.3K | ﹤0.01% | 1676 |
|
|
2020
Q2 | $2.93M | Sell |
222,546
-13,508
| -6% | -$178K | ﹤0.01% | 1492 |
|
|
2020
Q1 | $1.86M | Buy |
236,054
+91,877
| +64% | +$723K | ﹤0.01% | 1615 |
|
|
2019
Q4 | $2.98M | Sell |
144,177
-26,990
| -16% | -$559K | ﹤0.01% | 1580 |
|
|
2019
Q3 | $2.35M | Sell |
171,167
-49,732
| -23% | -$682K | ﹤0.01% | 1682 |
|
|
2019
Q2 | $2.72M | Buy |
220,899
+21,184
| +11% | +$261K | ﹤0.01% | 1608 |
|
|
2019
Q1 | $2.49M | Buy |
199,715
+62,399
| +45% | +$779K | ﹤0.01% | 1627 |
|
|
2018
Q4 | $1.55M | Sell |
137,316
-50,687
| -27% | -$574K | ﹤0.01% | 1812 |
|
|
2018
Q3 | $3.52M | Buy |
188,003
+19,888
| +12% | +$372K | 0.01% | 1445 |
|
|
2018
Q2 | $4.35M | Sell |
168,115
-33,226
| -17% | -$859K | 0.01% | 1279 |
|
|
2018
Q1 | $4.51M | Sell |
201,341
-7,359
| -4% | -$165K | 0.01% | 1206 |
|
|
2017
Q4 | $5.23M | Buy |
208,700
+84,572
| +68% | +$2.12M | 0.01% | 1100 |
|
|
2017
Q3 | $3M | Buy |
124,128
+3,883
| +3% | +$93.9K | 0.01% | 1360 |
|
|
2017
Q2 | $2.43M | Buy |
120,245
+56,835
| +90% | +$1.15M | 0.01% | 1441 |
|
|
2017
Q1 | $1.71M | Buy |
63,410
+42,910
| +209% | +$1.15M | ﹤0.01% | 1628 |
|
|
2016
Q4 | $390K | Buy |
+20,500
| New | +$390K | ﹤0.01% | 2472 |
|